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Abstract
The whole-body deletion of small heterodimer partner (SHP) in mice is associated with
protection from diet-induced obesity and hepatic steatosis upon feeding of a western diet. This
protection was reported to be mediated through decreases in hepatic gene expression for
lipogenesis, as well as increases in gene expression for fatty acid oxidation. SHP has been
known to regulate the expression of the CYP7A1 gene, encoding the rate-limiting enzyme for
bile acid synthesis, thereby altering the bile acid pool. The effects of this altered bile acid profile
on the gut microbiome are unknown, as some bacteria in the gut are responsible for bile acid
metabolism while others are killed by the detergent effect of bile acids. This study shows that
mice without SHP display a distinctly different microbiome from wild-type mice, characterized
by a reduction of phylogenetic diversity and an increased abundance of the Bacteroidetes
phylum with a proportional decrease in Firmicutes abundance. Cohousing mice led to increased
microbiome similarity between genotypes, with a blunted reduction of phylogenetic diversity in
SHP-/- mice. Furthermore, cohoused mice displayed reductions in the hepatic gene expression
for synthesis of fatty acids, lipid droplets, and bile acids without altering fat and liver mass.
These results may suggest a relationship between SHP and the microbiome in the development
of diet-induced obesity but not hepatic steatosis.

Introduction
Small heterodimer partner (SHP) is an orphan nuclear hormone receptor involved in the
regulation of glucose and lipid metabolism homeostasis [1]. SHP does not bind DNA due to a
lack of DNA binding domains; it represses transcription through interactions with other
transcription factors [1, 3]. As SHP is involved in the negative feedback regulation of bile acid
synthesis, the deletion of SHP leads to increased expression of genes involved in bile acid
synthesis [3]. Upon feeding of a western diet (WD) containing high fat, carbohydrate, and
cholesterol, SHP-/- mice displayed reduced fat accumulation in the liver [1]. Protection from
diet-induced obesity (DIO) is also associated with the SHP-/- genotype through increased energy
expenditure from brown adipose tissue, and increased β-oxidation gene expression reduces the
accumulation of triglyceride lipid droplets in liver cells (hepatic steatosis) [1, 5]. Hepatic
steatosis is commonly associated with insulin resistance and other metabolic disorders such as
DIO and type 2 diabetes [6, 7]. More than 75% of obese patients and 25% of the general
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population are affected by this disorder [6, 8]. Hepatic steatosis can progress to nonalcoholic
fatty liver disease when an excess of free fatty acids triggers lipotoxicity and activates
inflammatory pathways, and progression to nonalcoholic steatohepatitis occurs when
inflammation and fibrosis causes damage to the hepatocytes [6, 9].
The gut microbiota also plays a major role in metabolism and formation of DIO [10].
The phyla Bacteroidetes and Firmicutes, which represent over 90% of the bacterial species in
both mice and humans, are partially responsible for the energy released from the diet [11].
Traditionally, lean subjects display decreased populations of Firmicutes and increased
Bacteroidetes, while obese subjects display increased populations of Firmicutes and decreased
Bacteroidetes with reductions in overall diversity of the microbiome [12]. Gut bacteria are also
involved in the metabolism of bile acid through the deconjugation, dehydrogenation, and
dehydroxylation of primary bile acids for use in anaerobic fermentation [7]. In addition to
providing energy for bacterial metabolism, the metabolism of primary bile acids forms secondary
bile acids with altered antibacterial properties [13, 14]. Through detergent properties, bile acids
can disrupt the lipid bilayer of bacterial cell membranes and damage arrangements of nucleic
acids and proteins [15]. Several Bacteroides, Lactobacillus, and Bifidobacterium species are
well known for their role in deconjugation of hydrophobic primary bile acids to produce
secondary bile acids with reduced antibacterial effect [15, 16]. Dehydroxylation of primary bile
acids performed by members of genus Eubacterium and Clostridium produces secondary bile
acids of higher hydrophobicity, which therefore increases the antibacterial effect [16]. Bacterial
susceptibility to bile acid-mediated damage is widely variable depending on species and
environment [13, 16].
SHP represses bile acid synthesis through its action on the liver enzymes in the
cytochrome P450 family, CYP7A1 and CYP8B1 [1]. CYP7A1 hydroxylates cholesterol as the
rate-limiting first enzyme for the classical pathway of bile acid synthesis, followed by CYP8B1
to produce cholic acid, a hydrophilic primary bile acid [1, 14, 17]. The hydrophobic primary bile
acid, chenodeoxycholic acid, can also be produced from CYP7A1 without CYP8B1, or through
CYP7B1 in an alternate pathway [17]. Mice then convert chenodeoxycholic acid to α- and βmuricholic acid to complete the synthesis process (Supp. Fig. 1) [18]. After synthesis, these
primary bile acids are conjugated in mice using dietary taurine before being secreted from the
liver for storage in the gallbladder [14]. Following release from the gallbladder and passage
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through the intestines, intestinal enterocytes reabsorb approximately 95% of the bile acids for
return to the liver using the circulatory system, where the remainder is lost into feces [15, 19].
Once returned to hepatocytes, FXR is activated and induces SHP to inhibit CYP7A1 as a
negative feedback loop on bile acid synthesis [20]. SHP further inhibits cholic acid production
through repression of CYP8B1, also of the classical synthesis pathway [19]. The deletion of
SHP leads to increased production of hydrophilic bile acids through derepression of both
CYP7A1 and CYP8B1, causing higher production of cholic acid with reduced production of both
α- and β-muricholic acid [3, 20, 21].
SHP also influences hepatic expression of genes involved in de novo fatty acid synthesis
and lipid accumulation. The transcription factor SREBP-1c activates the fatty acid synthesis
pathway in response to insulin, allowing FAS downstream to build the saturated fatty acid
palmitate from acetyl-CoA and malonyl-CoA [22, 23]. While these fatty acids can be used to
synthesize cell membranes and other intracellular components, their abnormal accumulation
inside hepatocytes can inhibit glucose uptake and lead to insulin resistance or the formation of
steatosis [22, 23]. WD feeding leads to increased fatty acid synthase (Fasn) expression to
produce fatty acids [24-26]. CIDEC also promotes the formation of lipid droplets from buildup
of these intracellular fatty acids [24, 27]. The deletion of SHP protects from hepatic steatosis by
inhibiting CIDEC activation and upregulating the gene expression of CPT1A and ACOX1,
involved in the β-oxidation of fatty acids [1, 28, 29]. CPT1A facilitates transport of long-chain
fatty acids into the mitochondria for β-oxidation, and ACOX1 oxidizes very long-chain fatty
acids that are esterified with CoA to begin the β-oxidation process in the peroxisome [25, 30].
Previous studies have shown that the deletion of SHP increases the amount of hydrophilic
bile acids in the pool, which is predicted to affect the structure of the microbiome [3, 13-15].
Therefore, 16S tag pyrosequencing was utilized to elucidate the specific effects of SHP deletion
on the gut bacteria, and also to confirm the similarities in microbiome composition associated
with cohousing mice. Cohousing both genotypes together alleviates the difference in diversity
between genotypes, and these mice also display reduced expression of hepatic genes for βoxidation, and synthesis of fatty acids, lipid droplets, and bile acids. Targeting the impacts of
SHP gene expression will also help elucidate the impact of the SHP-dependent pathway of bile
acid regulation, and perhaps even provide greater insight into other factors involved in the
increased protection of SHP-/- mice from DIO and hepatic steatosis [1]. The relationship of
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phenotypic changes associated with alterations in the gut microbiome in mice lacking SHP is
also unknown. This study shows that SHP-/- mice display a distinct microbiome from the wildtype genotype (WT) through alterations in the ratio of Firmicutes to Bacteroidetes with changes
in phylogenetic diversity.

Materials and Methods
Mouse Studies. Separate cages consisted of a single genotype of littermates, and
cohoused cages consisted of equal numbers of WT C57BL/6NHsd and SHP-/- mice also based on
a C57BL/6NHsd background. Age-matched mice were housed in cages of four, and cohoused
cages were set up immediately after weaning at three weeks of age. Cohoused cages were used
to reduce microbiome-associated differences and isolate the physiological differences associated
with the altered bacterial composition. All cages were housed in a temperature and lightcontrolled room on a 12-hour light-dark cycle (06:30 on, 18:30 off). Diet and water was
available ad libitum, consisting of either laboratory chow (5001, Lab Diet, MO) for chow diet
(CD) or WD consisting of high sucrose and 42% energy from saturated fats (TD.88137, Harlan
Labs, IN). All mice were fed CD until WD was introduced at eight weeks of age and fed to mice
for twenty-four weeks. Body weight was taken on average every seven days following WD
administration. After twelve total weeks of WD, a glucose tolerance test was performed after
overnight fasting. Following intraperitoneal injection of 1 g/kg glucose solution, blood glucose
was checked at thirty minute intervals for two hours using a Bayer Contour Next EZ handheld
blood glucose meter (Bayer HealthCare, IN). After fourteen total weeks of western diet, mouse
body composition was determined using an EchoMRI machine (EchoMRI, TX). All animals
were handled humanely, and all protocols were approved by the Institutional Animal Care and
Use Committee at NEOMED.
Tissue Collection and Measurement of Gene Expression. Tissue collection was
performed after 6 months of WD feeding. Liver samples were used for gene expression, from
which total RNA was isolated using a TRIzol solution (Life Tech, NY) [31]. cDNA was
synthesized from total RNA using PrimeScript RT master mix (Clontech, CA), and qPCR was
run to determine mRNA levels using an Applied Biosystems Gene Amp PCR System 9700 realtime PCR machine with iTaq Universal SYBR supermix (both from BioRad, CA). GAPDH was
used as an internal control, and relative expression was determined from ΔCt values normalized
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to the expression of separate WT mice fed CD. Primer sequences were obtained from
http://pga.mgh.harvard.edu/primerbank, and the pathway flowchart used PathVisio v3.2.1 [5].
Gut Microbiome Profiling. Fecal samples were collected for all cages immediately
before initiation of WD, and again after ten weeks of WD feeding. Mice were placed into an
autoclave-sterilized cage for thirty-six hours with sterilized water and normal diet to maintain
microbiome consistency. All feces was collected in a laminar flow hood, and stored at -80oC
until use. Bacterial DNA was then extracted using a Fecal DNA MiniPrep kit (Zymo Research,
CA), and PCR was performed using primers targeting the V3 and V4 region of the 16S rRNA
gene (Integrated DNA Technologies, IA). The primer list is found in Table 1. Pippin Prep
cassettes (1.5% agarose) were used for purification and targeted DNA collection (Sage Science,
MA), and purified samples were quantified via Qubit spectroscopy (Qubit Systems, ON, Canada)
using a dsDNA high-sensitivity assay kit (Invitrogen-ThermoFisher, NY). Samples were sent to
the Advanced Genetic Technologies Center (University of Kentucky, Lexington) for Illumina
MiSeq tag pyrosequencing run on a dual-indexed, 250 base pair flowcell (Illumina, CA). Using
QIIME v1.9.1, output files were demultiplexed, and operational taxonomic unit (OTU) picking
was done using an open-reference algorithm [32, 33]. For samples with greater than 104,006
sequence count, beta diversity principal coordinates analysis was estimated using unweighted
UniFrac and Adonis Permanova to measure significance (p-value) and an effect size (R2) to
explain variation, and
Table 1: The list of primers used for Illumina PCR (IDT, IA)

rarefied alpha diversity
using Faith’s phylogenetic
diversity (PD) whole tree
analysis [2, 4]. Unless
specified otherwise, a
homoscedastic Student’s ttest was used to compare
two different groups, where
P < 0.05 was considered

Forward primers (515F-IL)

5’

Illumina Adapter Sequence Barcode Index
AATGATACGGCGACCACCGAGATCTACAC
ATCGTACG
AATGATACGGCGACCACCGAGATCTACAC
ACTATCTG
AATGATACGGCGACCACCGAGATCTACAC TAGCGAGT
AATGATACGGCGACCACCGAGATCTACAC
CTGCGTGT
AATGATACGGCGACCACCGAGATCTACAC
TCATCGAG
AATGATACGGCGACCACCGAGATCTACAC CGTGAGTG
AATGATACGGCGACCACCGAGATCTACAC
GGATATCT
AATGATACGGCGACCACCGAGATCTACAC GACACCGT

Pad
TATGGTAATT
TATGGTAATT
TATGGTAATT
TATGGTAATT
TATGGTAATT
TATGGTAATT
TATGGTAATT
TATGGTAATT

Linker
GT
GT
GT
GT
GT
GT
GT
GT

Gene Specific Primer
3’
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA
GTGCCAGCMGCCGCGGTAA

Reverse primers (806R-IL)
Name 5’
Illumina Adapter Sequence Barcode Index
Pad
R1)
CAAGCAGAAGACGGCATACGAGAT
AACTCTCG AGTCAGTCAG
R2)
CAAGCAGAAGACGGCATACGAGAT
ACTATGTC AGTCAGTCAG
R3)
CAAGCAGAAGACGGCATACGAGAT
AGTAGCGT AGTCAGTCAG
R4)
CAAGCAGAAGACGGCATACGAGAT
CAGTGAGT AGTCAGTCAG
R5)
CAAGCAGAAGACGGCATACGAGAT
CGTACTCA AGTCAGTCAG
R6)
CAAGCAGAAGACGGCATACGAGAT
CTACGCAG AGTCAGTCAG
R7)
CAAGCAGAAGACGGCATACGAGAT
GGAGACTA AGTCAGTCAG
R8)
CAAGCAGAAGACGGCATACGAGAT
GTCGCTCG AGTCAGTCAG

Linker
CC
CC
CC
CC
CC
CC
CC
CC

Gene Specific Primer
3’
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT
GGACTACHVGGGTWTCTAAT

Name
F1)
F2)
F3)
F4)
F5)
F6)
F7)
F8)

significantly different.
Values are averages ± SD
unless otherwise listed.

The adapter, pad, linker, and gene-specific primer sequence is common within
the forward and the reverse primers. The barcode indices are used to generate
a unique string for paired-end sequencing that is recognized for sorting OTU
sequences [4].
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Results and Discussion
Cohousing genotypes alters body weight gain. In order to explore a potential linkage between
microbiome and the lean phenotype observed in SHP-/- mice, this experiment cohoused WT and
SHP-/- mice. It was expected that the coprophagic tendencies of mice would lead to sharing of
gut bacteria, and previous studies have reported complete sharing of microbiome population
within four weeks [34]. Body weight from separate cages matched previous studies, as the
deletion of SHP was associated with significantly reduced weight gain upon WD feeding (Fig.
1C) [1]. Cohousing led to a dramatic decrease in the protection from body weight increases (Fig.
1B & 1D) in SHP-/- mice, as mice fed CD or WD displayed a nearly equalized average body
weight between genotypes. This suggests the role of the gut bacteria in the protection upon SHP
deletion from DIO formation.
A

B

C

D

Fig. 1: Body weight changes associated with cohousing WT and SHP-/- mice over the experimental period, beginning
with the day WD was first administered at eight weeks of age. Values are average of total body weight per cage ± SD
for each group (n=4 for all). Student’s homoscedastic t-test was used for significance, where P < 0.05 was considered
significant.
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Deletion of SHP alters the microbiome. Sequencing of mouse feces was then performed to
examine the changes in bacterial composition in the guts of both separated and cohoused
animals. It was known that WD feeding and DIO led to an increase in the abundance of
Firmicutes and a decreased abundance of Bacteroidetes, but the specific effect of SHP deletion
on the gut microbiome was previously unknown [35]. Sequencing of the gut microbiome before
and after feeding WD for 10 weeks revealed an altered bacterial composition due to diet, mouse
genotype, and cohoused caging condition. Following 10 weeks of WD feeding, significantly
distinct clusters of microbiome composition were seen between genotypes in separated cages
(Supp. Fig. 2A). Cohousing cages alleviated these genotype-associated clusters, although
significantly different clustering due to diet alterations remained (Supp. Fig. 2B). Ageassociated changes in the microbiome, independent of diet, concurred with previous studies as
well, as significantly distinct clusters appeared for both genotype and time (Supp. Fig. 2C & 2D)
[36-38]. This suggests that diet may be a more potent influence on the microbiome than
genotype.
On CD, the phylogenetic diversity of sequenced samples was not significantly different,
although SHP-/- mice tended to display a slight reduction of diversity (Fig. 2A). However, ten
weeks of WD feeding led to decreased diversity, as expected for both SHP-/- and WT mice (Fig.
2B) [35]. Cohoused cages display further reductions in diversity resulting from the deletion of
SHP (Fig. 2C). Additionally, the deletion of SHP led to an increased diversity with CD feeding
that was reversed upon WD feeding (Fig. 2B). The deletion of SHP was also linked to a reduced
OTU ratio of Firmicutes to Bacteroidetes, regardless of time period or diet (Fig. 2D). One
exception was seen in cohoused SHP-/- mice upon 10 weeks of WD feeding, which displayed a
drastic increase in Firmicutes. This difference may reflect the increased Firmicutes abundance
typically associated with WD feeding, although this dysbiosis was not uniform for all mice fed
WD for 10 weeks [35, 39, 40]. It is hypothesized that these effects may be caused by alterations
in the bile acid pool caused by the deletions of SHP and WD feeding seen in previous studies [3,
13].
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Fig. 2: Analysis of sequencing samples (n=4 for all groups)
with greater than 104,006 sequence count. Values presented
are average + or – SD, where half confidence intervals are
shown to increase visibility. Mice are grouped by cagingtime period to compare the effects of diet alteration upon the
loss of SHP. Student’s homoscedastic t-test was used for
significance: # P < 0.05 and ## P < 0.01 for diet (CD-WD),
* P < 0.05 and ** P < 0.01 for genotype (WT-SHP-/-), and ^
P < 0.05 for caging (separate-cohoused) significance. (A)
Rarefied alpha diversity using Faith’s PD for separate cages
on CD before WD feeding began. No significance was
noticed for all data sets [2]. (B) Faith’s PD after 10 weeks
of WD feeding for separate cages. (C) Faith’s PD for
cohoused cages after 10 weeks of WD feeding. (D) Ratio of
Firmicutes to Bacteroidetes, measured by a ratio of OTU
count from sequenced feces. The groups are separated by
caging (Sep = Separate caging, and Co = Cohoused caging)
and time length of WD feeding to compare the effects of diet
alteration upon the deletion of SHP. Caging and diet are not
significant (P > 0.05).

D

Sequencing of the microbiome composition revealed that the sum of Firmicutes and
Bacteroidetes phyla account for 80-90% abundance on average, where the dominant bacteria
were consistently from classes Clostridia and Bacilli of the Firmicutes phylum, and class
Bacteroidia of the Bacteroidetes phylum (Supp. Fig. 3). Mice lacking SHP consistently
displayed large increases of class Bacteroidia with proportional decreases in Clostridia,
regardless of diet and length of diet. However, cohoused SHP-/- mice fed WD for 10 weeks
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displayed a dramatic increase in Clostridia that reflect the large increases seen in the
Firmicutes/Bacteroidetes ratio (Fig. 2D). However, there were several specific examples that
differed from previous studies. Increases in Erysipelotrichi class abundance have been linked to
the formation of hepatic steatosis and atherosclerosis formation, as the bacteria metabolize
choline into trimethylamine, which is then converted to toxic trimethylamine N-oxide in
hepatocytes and triggers cholesterol accumulation [7, 41]. In this study, only cohoused cages
displayed a markedly increased abundance in the Erysipelotrichi class, independent of genotype
and dietary alterations. Lastly, the deletion of SHP protected from increases in Bacilli
abundance upon feeding WD, as increases are associated with the formation of DIO [38].
Further analysis of sequencing data is also required to glean further knowledge from gut bacteria
changes. Sequencing after a longer period of WD feeding would show long-term effects of
chronic WD feeding and complement the gene expression results [35, 37]. Phylogenetic analysis
could be carried out with current data to build a tree comparing sample groups. To complement
relative ratios of bacterial OTUs presented, total number of fecal bacteria should be obtained
through either microscopy with fluorescent dye to target bacteria, or qPCR on the DNA extracted
from fecal samples using general primers to target the 16S rRNA gene [42, 43].

Cohoused caging reduces phenotypic differences. To explore the whole-body effects associated
with these microbiome changes, physiological testing was performed. As expected, SHP-/- mice
are also protected from body fat accumulation when compared to WT mice (Fig. 3A), even on
the liver (Fig. 3G) [1, 3]. However, cohoused mice displayed little differences from separated
cages in their body percentage of fat and lean mass (Fig. 3A & 3B) and liver weight (Fig. 3G).
This suggests that cohousing of SHP -/- mice was associated with loss of protection from fat
accumulation but independent of formation of hepatic steatosis. Although the deletion of SHP
typically results in greater glucose intolerance upon WD feeding, little difference in insulin
resistance was noticed between genotype, diet, or caging following a glucose tolerance test after
3 months of WD feeding (Fig. 3C-F). However, SHP-/- mice in separated cages fed CD in this
study displayed an abnormally increased tolerance (Fig. 3C) while no differences were noticed in
cages fed WD or cohoused (Fig. 3D-F) [1]. The increased similarity in body weight with
cohoused cages may be associated with the reduced genotypic difference in phylogenetic
diversity (Fig. 2A-C) and principal coordinates analysis clustering (Supp. Fig. 2). The large
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C

D

E

F

G

Fig. 3: Phenotype changes associated with differences in genotype over the experimental period. Each chart contains one diet
and caging condition, to compare differences associated with the loss of SHP, where sample number is equal (n=4) for all
groups and tests (Sep = Separate Caging, and Co = Cohoused caging). Student’s homoscedastic t-test was used to calculate
significance for all tests. # P < 0.05, ## P < 0.01, and ### P < 0.001 for diet (CD-WD); * P < 0.05, ** P < 0.01, and *** P <
0.001 for genotype (WT-SHP-/-); ^ P < 0.05 and ^^ P < 0.01 for caging (Separate-Cohoused). (A) Body composition through
lean and fat percentage of total body weight measured by EchoMRI after fourteen weeks of WD feeding. Values are the
average ± SD. (C, D, E, F) Glucose tolerance test performed after twelve weeks of WD feeding via peritoneal injection of 1
g/kg glucose solution with blood glucose measurements every thirty minutes afterward. Values are average + or – SD, where
half confidence intervals are shown to increase visibility between groups. (C) Glucose tolerance test for separate mice fed CD.
(D) Glucose tolerance test for cohoused mice fed CD. (E) Glucose tolerance test for separate mice fed WD. (F) Glucose
tolerance test for cohoused mice fed WD. (G) Liver weight as percent of total body weight after six months of WD feeding
following tissue collection. Values are the average percent body weight ± SD.
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abundance of Firmicutes in the cohoused SHP-/- mice fed WD for 10 weeks reflected the loss of
protection from fat accumulation, as a large abundance of Firmicutes is usually seen in mice with
DIO and increased body weight (Fig. 2D) [11, 35, 39]. However, cohousing buffered the loss of
diversity typically seen with WD feeding, which may protect from development of DIO (Fig.
2C) [35]. Insulin resistance testing proved inconclusive, as WD feeding failed to show
previously published resistance in mice lacking SHP (Fig. 3C-F) [1]. Future experiments could
focus on liver triglyceride and cholesterol quantification to complement the liver size presented
in this study. Hepatic lipidomics may also help explore the molecular lipid differences under
each caging, genotype, and diet condition, as increased levels of ceramides and other fatty acids
have been linked to the formation of insulin resistance [44-46].
Cohousing alters hepatic gene expression for β-oxidation, and fatty acid and bile acid synthesis.
Testing of hepatic gene expression was performed to determine the relationship of metabolic
phenotype with alterations in the microbiome. As SHP is involved in the repression of the bile
acid synthesis, enzymes for both the classical and alternate pathways were tested [3, 5]. Genes
involved in β-oxidation were also tested, as the deletion of SHP protects from hepatic steatosis
due to increases in β-oxidation gene expression [1, 3]. Lastly, expression of genes for the
synthesis of fatty acids and the accumulation of lipid droplets was tested, as the deletion of SHP
downregulates both pathways [1]. In the separate cages of this study, the deletion of SHP led to
significantly increased expression of bile acid synthesis genes from both the classical and
alternate pathways (Fig. 4A), and the SHP-/- mice displayed greater protection from fatty acid
synthesis and lipid droplet formation (Fig. 4B). Surprisingly, this protection was independent of
β-oxidation, as SHP-/- mice did not display the significantly upregulation of genes involved in βoxidation upon WD feeding as previous studies have shown (Fig. 4C) [1]. Cohousing mice led
to a generalized reduction in gene expression for bile acid, fatty acid, and lipid droplet synthesis
without altering the protection associated with the loss of SHP, suggesting the shared influence
of genetics and microbiome in the metabolic profile.
Contrary to previous studies, hepatic SHP gene expression was found to increase upon
WD feeding (Fig. 4A) [1]. Additionally, cohousing led to increases in SHP expression, causing
greater repression of CYP7A1 expression for bile acid synthesis in WT mice (Fig. 4A).
Derepression by the loss of SHP leads to increased expression of the three tested bile acid
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synthesis genes, CYP7A1, CYP8B1, and CYP7B1 (Fig. 4A) [1, 17]. However, cohoused mice
fed WD displayed a near-zero expression of the major bile acid synthesis genes from both
pathways, which will require further testing to elucidate the both the responsible mechanism and
its impact on the composition of the bile acid pool. Bile acid metabolomics could also be
performed in the lab of Dr. Leah Shriver (University of Akron, Department of Chemistry) to
elucidate specific composition of the bile acid, especially given the drastic reductions of bile acid
synthesis seen in cohoused mice fed WD (Fig. 4A).
WD feeding in separate cages led to increased expression of hepatic genes involved in
synthesis of fatty acids (FAS) and formation of lipid droplets (CIDEC) for both genotypes,
where the deletion of SHP protected from the significant increases seen in WT mice (Fig. 4B) [1,
44, 47]. Cohoused cages displayed reduced overall expression of both FAS and CIDEC,
although the protection associated with the loss of SHP remained. The hepatic β-oxidation gene
expression of CPT1A and ACOX1 (Fig. 4C) largely agreed with previous studies for separate
cages [1]. However, separate WT mice fed WD displayed an abnormally high expression of
ACOX1, signifying the possible dysregulation of fatty acid metabolism, as CIDEC expression is
also increased. Cohoused cages display an altered expression, as WD feeding reduces the
expression of both genes with the loss of protection associated to the loss of SHP (Fig. 3G).
These reductions in CIDEC expression should suggest that the altered microbiome from
cohousing result in reduced formation of hepatic steatosis (Fig. 4B) [24]. However, the reduced
expression of fatty acid synthesis genes upon cohousing did not influence the overall liver
weight, suggesting that overall levels of steatosis are unaffected (Fig. 3G).
In the future, gene expression of tissue samples from the ileum may also be used to
examine genes involved with absorption of bile acid, transport into the circulatory system, and
the strength of the intestinal barrier. Intestinal FAS gene expression induces de novo lipogenesis
and promotes intestinal barrier strength, where reduced expression leads to increased leakiness
that allows bacterial byproducts to enter circulation and increases cytokines involved in
inflammation [41]. Bacterial byproducts absorbed into the circulatory system can activate Tolllike receptors, such as LPS activating Toll-like receptor 4, resulting in a release of cytokine
proteins like IL-1β that induce inflammation [9, 48]. In the liver, IL-1β leads to the activation of
TNFα, which can induce hepatic steatosis [41, 48].
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A

B
Fig. 4: Hepatic gene expression profile
after six months of WD feeding. Charts
are grouped (n=6 for cohoused WD cage,
n=4 for all other groups) by diet and
caging condition, to directly compare
differences associated with SHP deletion.
SHP itself was checked, as well as bile
acid synthesis for the classical pathway
(CYP7A1 and CYP8B1) and alternate
pathway (CYP7B1). β-oxidation gene
expression was checked for mitochondrial
(CPT1A) and peroxisomal (ACOX1).
Fatty acid synthesis gene expression was
checked for palmitate synthesis (FAS) and
lipid droplet accumulation (CIDEC).
Values were obtained from qPCR ∆Ct
values with GAPDH internal control, and
normalized to the expression of separate
WT mice fed only CD for relative gene
expression. Values are averages ± SD.
Student’s homoscedastic t-test was used to
determine significance: # P < 0.05 and ##
P < 0.01 for diet (CD-WD), * P < 0.05 and
** P < 0.01 for genotype (WT-SHP-/-), and
^ P < 0.05 and ^^ P < 0.01 for caging
(separate-cohoused).

C
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Summary. This study revealed that SHP-/- mice displayed a distinct microbiome from WT mice,
manifested in principal coordinates analyses, a significantly reduced Firmicutes/Bacteroidetes
ratio, and loss of phylogenetic diversity upon WD feeding. Protection from hepatic steatosis
upon the deletion of SHP, seen through reduced liver percentage of total body weight, was
mediated by downregulation of fatty acid synthesis and lipid droplet formation, although the
expected increases in β-oxidation were not noticed. SHP-/- mice also displayed derepression of
genes in bile acid synthesis.
Cohousing of WT and SHP-/- genotypes alleviated the loss of phylogenetic diversity seen
in SHP-/- mice. The protection from DIO in SHP-/- mice was also reduced upon cohousing, as
genotypic differences in body weight and fat accumulation were lost. However, these body
weight changes were not associated with altered protection from the development of hepatic
steatosis. Cohousing resulted in generalized repression of the hepatic gene expression for βoxidation and synthesis of fatty acids, lipid droplets, and bile acids, where WD feeding caused
significantly greater reductions in gene expression for bile acid synthesis. However, the effects
of SHP deletion on gene expression were still present in cohoused cages, as mice lacking SHP
still displayed increases in bile acid synthesis gene expression and decreases in expression of
genes involved in synthesis of fatty acids and lipid droplets.
In conclusion, this study revealed that the protection from DIO and hepatic steatosis from
the deletion of SHP was associated with alterations in the gut microbiome and altered gene
expression. Furthermore, cohousing WT and SHP-/- genotypes to equalize the gut bacteria led to
decreased protection from DIO upon SHP deletion while maintaining protection from hepatic
steatosis.
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Supplemental Figures
Supp. Fig. 1: Simplified bile acid synthesis pathway, showing only the major proteins for each
conversion, and sites of SHP inhibition. The major metabolites are shown in blue boxes/text,
primary bile acids are yellow-green, major enzymes are black, and regulatory proteins to
highlight the involvement of SHP in negative feedback are red. (Adapted from [17, 49]).
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Supp. Fig. 2: Three-dimensional principal coordinates analysis plots made with QIIME using
unweighted UniFrac beta-diversity data from samples with greater than 104,006 sequences each.
Sample size is listed next to each color coordination for combination of genotype and diet
condition. Each plot shows distinct alterations in bacterial clustering related to diet, genotype,
time, and caging. Adonis Permanova was used to calculate the effect size and significance of
each genotype-diet combination of samples: * P < 0.05 for diet (CD-WD), # P < 0.05 for
genotype (WT-SHP-/-), and NS is not significant (P > 0.05). (A) Separately caged mice after 10
weeks of WD, comparing the effects of genotype and diet. (B) Cohoused cages after 10 weeks
of WD, also comparing the effects of genotype and diet. (C) Separately caged mice only fed
CD, comparing the microbiome composition similarities between genotype and temporal
changes. (D) Separately caged mice only fed WD, also comparing the microbiome composition
similarities between genotype and temporal changes.
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Supp. Fig. 3: Comparison of microbiome composition, via percent of class phylogeny OTU
abundance. Groups (n=4 for all) are separated by caging-time period combinations to directly
compare diet changes upon the loss of SHP. The bolded classes in the legend are three major
classes that are consistently seen, Clostridia, Bacilli, and Bacteroidia. These classes compose at
least 4.50% of the microbiome on average, seen in exact compositional abundance on the right.
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